EMPathy BREAST CANCER NETWORK

Masthead Image

EMPathy Breast Cancer Network: News


Upcoming Events

Convener for TEMTIA-VII

We are pleased to announce that EMPathy BCN chief investigator Rik Thompson will be convening the 7th EMT (Epithelial-Mesenchymal Transition) International Meeting: TEMTIA-VII which will be held from 11th-14th, October 2015 in Melbourne, Australia.



2014

Major Publication in The EMBO Journal

Congratulations to EMPathy BCN chief investigator Greg Goodall and his team on publishing a key article on The EMBO Journal ,"Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion".

NBCF Infrastructure Grant

Congratulations to EMPathy BCN chief investigator Robin Anderson for being awarded the NBCF Infrastructure Grant, "NBCF Repository of Primary tumours and Metastases from Breast Cancer patients". This would be a five year program aimed to collect tissues for multiple research projects.



2013

Finalist
Australian Museum Eureka Prizes

Congratulations to EMPathy BCN chief investigator Christobel Saunders and her colleagues who are finalists in the 2013 ANSTO Eureka Prize for Innovative Use of Technology.

New Consumer Representative

A warm welcome to Kym Berchtenbreiter who has joined as a BCNA Consumer Representative from March 2013.

In Memoriam

We are sad to learn that Niki Aravanis had passed away after her battle with metastatic breast cancer in January 2013. Niki joined us last year as a BCNA Consumer Representative and generously gave her time, interest and enthusiasm to bring about better outcomes for people with breast cancer, especially metastatic breast cancer. Niki's professional input and fresh approach, and her gentle, private personality were very much valued and will be much missed.


2012

Consumer Representative

Very best wishes and a heart-felt thank you to Jennifer Johnston, who has resigned (in November 2012) for health reasons after only recently joining us as a BCNA Consumer Representative. Jen focused on metastatic breast cancer, which she felt continues to be overlooked in the media and, to some extent, even in the breast cancer community (read her contribution to the   Cancer Action Victoria Newsletter 5, Spring 2012 here).

Role of VLSCI bioinformaticians and supercomputers in EMPathy research

VLSCI Science Story 8

Co-convenor of the 14th International Biennial MRS Conference

We are pleased to announce that EMPathy BCN chief investigator Rik Thompson was a co-convenor of the 14th International Biennial Metastasis Research Society (MRS) Conference, from 2-5th September, 2012, held in Brisbane. Rik has been the President of the International Metastasis Research Society for years 2010-2012.

New Consumer Representatives

Niki Aravanis and Jennifer Johnston have agreed to join as BCNA Consumer Representatives from February 2012. We are very pleased to have them on board “ Niki and Jen, who have completed the Breast Cancer Network Australia Advocacy & Science Training (www.bcna.org.au) to represent the point of view of Australians affected by breast cancer, will also contribute their valuable experience, skills and dedication to the program.


2011

Founding of Australasian Metastasis Research Society

Congratulations to EMPathy BCN chief investigator Rik Thompson for founding of the Australasian Metastasis Research Society interest group,OzMRS. Rik was the Co-Convenor of the Inaugural OzMRS Metastasis Symposium on 27th September, 2011, held in Melbourne.

In Memoriam

Sally Hodgkinson, our friend and consumer advocate, has passed away after a long battle with breast cancer. Sally's contributions to the program were invaluable as she tirelessly focused on the work ahead with characteristic down-to-earth demeanour. Her experience and personal perspective embodied the reality behind breast cancer statistics and were a continual, stark reminder to us that research breakthroughs cannot come soon enough. Sally was inspirational and will be much missed, but her commitment and passion will continue to spur us on in the fight against breast cancer.